| | Identification | Back Directory |  | [Name] 
 3-(3,4-dihydroxyphenyl)-2-hydroxy-propanoic acid
 |  | [CAS] 
 23028-17-3
 |  | [Synonyms] 
 (Rac)-Danshensu
 Danshensu lactic acid
 (Rac)-Salvianic acid A
 α-Hydroxyhydrocaffeic acid
 3,4-dihydroxyphenyllactic acid
 3-(3,4-Dihydroxyphenyl)lactic acid
 α,3,4-Trihydroxybenzenepropanoic acid
 α,3,4-Trihydroxybenzenepropionic acid
 Benzenepropanoic acid, α,3,4-trihydroxy-
 alpha,3,4-Trihydroxy-benzenepropanoic acid
 3,4-DIHYDROXYPHENYLLACTIC ACID SODIUM SALT 90%
 2-Hydroxy-3-(3,4-dihydroxyphenyl)propanoic acid
 2-Hydroxy-3-(3,4-dihydroxyphenyl)propionic acid
 3-(3,4-Dihydroxyphenyl)-2-hydroxypropionic acid
 3-(3,4-dihydroxyphenyl)-2-hydroxy-propanoic acid
 |  | [Molecular Formula] 
 C9H10O5
 |  | [MOL File] 
 23028-17-3.mol
 |  | [Molecular Weight] 
 198.17
 | 
 | Chemical Properties | Back Directory |  | [Boiling point ] 
 481.5±40.0 °C(Predicted)
 |  | [density ] 
 1.546±0.06 g/cm3 (20 ºC 760 Torr)
 |  | [form ] 
 Solid
 |  | [pka] 
 3.82±0.10(Predicted)
 |  | [color ] 
 Light yellow to yellow
 |  | [LogP] 
 0.045 (est)
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 (Rac)-Salvianic acid A is the racemate of Salvianic acid A (HY-N1913). Salvianic acid A, an orally active phenolic compound, can induce Nrf2/HO-1 activation and inhibition of NF-κB pathway. Danshensu has anti-oxidation, anti-apoptosis, anti-lung inflammatory and has the potential for COVID-19, cardiovascular and cerebrovascular diseases research[1][2][3].
 |  | [Definition] 
 ChEBI: 3-(3,4-dihydroxyphenyl)lactic acid is a 2-hydroxy monocarboxylic acid and a member of catechols. It is functionally related to a rac-lactic acid. It is a conjugate acid of a 3-(3,4-dihydroxyphenyl)lactate.
 |  | [References] 
 [1] Wei Wang, et al. Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation. Acta Pharmacol Sin. 2022 Apr;43(4):771-780. DOI:10.1038/s41401-021-00714-4
 [2] V Bharath Kumar, et al. Sodium Danshensu Inhibits Oral Cancer Cell Migration and Invasion by Modulating p38 Signaling Pathway. Front Endocrinol (Lausanne). 2020 Sep 30:11:568436. DOI:10.3389/fendo.2020.568436
 [3] Chen Yu, et al. Danshensu attenuates cisplatin-induced nephrotoxicity through activation of Nrf2 pathway and inhibition of NF-κB.  Biomed Pharmacother. 2021 Oct:142:111995. DOI:10.1016/j.biopha.2021.111995
 | 
 | 
                    
                        
                            | Company Name: | CHEMICAL LAND21 |  
                            | Tel: | 82- 2 -783 - 8063 |  
                            | Website: | www.chemicalland21.com |  |